🏥 Meet the CEO: iRemedy

Already raised $50k+   iRemedy ~/AAQRxQA~/RgRmfCzoP0SeaHR0cHM6Ly9yZXB1YmxpYy5jb20vaXJlbWVkeT91dG1fc291cmNlPXJlcHVibGljLmNvJnV0bV9tZWRpdW09ZW1haWwmdXRtX2NhbXBhaWduPW5ld3NsZXR0ZXJfbWFpbGVyLndlZWtseV9uZXdzbGV0dGVyJnV0bV9jb250ZW50PWlyZW1lZHlfYWxsJnV0bV90ZXJtPWlyZW1lZHlXA3NwY0IKZJHop5lk_R1gzFIbdHJpc3RyYW1iYWxkd2luOTBAZ21haWwuY29tWAQAAAHO Today we'd like you to hear directly from iRemedy’s CEO, Tony Paquin, about what sets iRemedy Healthcare apart.   A Word from the iRemedy CEO Hi {NAME}, Each of us is profoundly affected by the success or failure (all too often) of how healthcare is delivered in America.. As a Co-Founder and CEO of iRemedy Healthcare, I wanted to personally reach out to you and share our company's story and mission. It's a passion of mine to tackle long-standing problems and find innovative solutions, and I believe that our mission holds immense importance. Like many Americans, I became deeply alarmed by the sudden shortages of vital medical supplies and drugs during the COVID pandemic, as well as the increasing costs of healthcare. The situation simply cannot continue, and we made the decision to take action. Healthcare is personal—it affects each and every one of us. During the pandemic, our country's medical supply distribution system showed its vulnerability and lack of innovation. The lack of information and an unstable supply chain brought our nation to its knees, resulting in the loss of too many lives. It became apparent that the traditional approach to delivering critically needed supplies was antiquated and inadequate. What most people don't realize is that over the past three decades, our country has outsourced the manufacturing of medical supplies and pharmaceuticals. The majority of these essential products are now produced in Asia, primarily in China. However, we are witnessing the emergence of new sources of medical supplies around the world, including a renewed focus on manufacturing within the USA. To address this crisis head-on, iRemedy Healthcare has developed a proprietary AI-driven medical supply channel. This innovative platform allows us to swiftly locate and catalog the world's medical supply sources. Recognizing that solving the global medical supply crisis would require next-generation technology, I had the privilege of bringing on board Jim Harding, the man behind the creation of the Amazon marketplace during his time as the VP of Technology at Amazon. Together, Jim and I have developed technology that transforms the Internet into an extensive database. This forms the foundation of our Universal Health and Medical Products Catalog (the 'UHMPC'), a single-source supply e-commerce store with the vision of becoming the world's largest directory of medical supplies. With the power of AI, we can effectively discover, build, and maintain these comprehensive catalogs. The global medical supply industry is currently valued at over $100B, and that number continues to rise daily. I want to emphasize the deeply personal nature of healthcare because it impacts your family and mine.. The absence of access to critical supplies can cause delays in surgeries, hinder recovery processes, and, in some cases, even lead to fatalities. This is a reality we cannot allow to persist. Our early investors include dedicated doctors and healthcare professionals from different corners of the country who share our vision. Now, I turn to you. We need individuals like yourself who understand the gravity of the situation and recognize the importance of our mission. This is not a matter we can afford to delay any further. Our team is working tirelessly to locate and deliver the medical supplies that your doctors, surgeons, and everyday people desperately need for a healthier America, and in the process reduce the overall cost of providing care. By investing in iRemedy, you will play a vital role in shaping a new era of lower costs, improved access to urgently needed medical supplies, and fair pricing for America's frontline healthcare workers. I’d like to thank Republic for partnering with us on this mission and invite you to visit our offering at their site. Thank you for showing genuine interest in iRemedy. Together, we have the power to drive change and make a meaningful impact. Warm regards, Tony Paquin CEO iRemedy Healthcare [View iRemedy on Republic](~/AAQRxQA~/RgRmfCzoP0SeaHR0cHM6Ly9yZXB1YmxpYy5jb20vaXJlbWVkeT91dG1fc291cmNlPXJlcHVibGljLmNvJnV0bV9tZWRpdW09ZW1haWwmdXRtX2NhbXBhaWduPW5ld3NsZXR0ZXJfbWFpbGVyLndlZWtseV9uZXdzbGV0dGVyJnV0bV9jb250ZW50PWlyZW1lZHlfYWxsJnV0bV90ZXJtPWlyZW1lZHlXA3NwY0IKZJHop5lk_R1gzFIbdHJpc3RyYW1iYWxkd2luOTBAZ21haWwuY29tWAQAAAHO)   Highlights are derived, and based entirely upon the Issuer’s representations. Prior results do not guarantee future success. Images provided by the issuer. Investments in private companies are particularly risky and may result in total loss of invested capital. [Form CRS: Client Relationship Summary.](~/AAQRxQA~/RgRmfCzoP0QyaHR0cHM6Ly9maWxlcy5icm9rZXJjaGVjay5maW5yYS5vcmcvY3JzXzI5MTM4Ny5wZGZXA3NwY0IKZJHop5lk_R1gzFIbdHJpc3RyYW1iYWxkd2luOTBAZ21haWwuY29tWAQAAAHO) An offering statement relating to The iRemedy Healthcare Companies, Inc.’s Common Stock has been filed with the Securities and Exchange Commission and became qualified on February 13, 2023. Prior to making any investment in The iRemedy Healthcare Companies, Inc.’s Common Stock, you should review a copy of the offering circular or contact The iRemedy Healthcare Companies, Inc. by phone at (407) 395-4283. No offer to sell any securities, and no solicitation of an offer to buy any securities, is being made in any jurisdiction in which such offer, sale, or solicitation would not be permitted by applicable law. [Risks Related to this Offering](~/AAQRxQA~/RgRmfCzoP0RbaHR0cHM6Ly93d3cuc2VjLmdvdi9BcmNoaXZlcy9lZGdhci9kYXRhLzE2OTEyNDkvMDAwMTkwMzU5NjIzMDAwMTMwL2lyZW1lZHlfMjUzZzEuaHRtI2FfMDAwNFcDc3BjQgpkkeinmWT9HWDMUht0cmlzdHJhbWJhbGR3aW45MEBnbWFpbC5jb21YBAAAAc4~) This Reg A+ offering is made available through OpenDeal Broker LLC. This brief should not be construed as investment advice. Always consult with trusted professional advisors before making investments. Private investments are inherently illiquid and may result in total loss. Not [FDIC](~/AAQRxQA~/RgRmfCzoP0QVaHR0cHM6Ly93d3cuZmRpYy5nb3YvVwNzcGNCCmSR6KeZZP0dYMxSG3RyaXN0cmFtYmFsZHdpbjkwQGdtYWlsLmNvbVgEAAABzg~~) or [SIPC](~/AAQRxQA~/RgRmfCzoP0QVaHR0cHM6Ly93d3cuc2lwYy5vcmcvVwNzcGNCCmSR6KeZZP0dYMxSG3RyaXN0cmFtYmFsZHdpbjkwQGdtYWlsLmNvbVgEAAABzg~~) insured. Disclaimer: This email does not constitute an agreement to conduct transactions by electronic means and does not create any legally binding contract or enforceable obligation in the absence of a fully signed written contract. OpenDeal Broker LLC (CRD 291387) is a registered broker-dealer and member of FINRA and SiPC ([BrokerCheck website](~/AAQRxQA~/RgRmfCzoP0QxaHR0cHM6Ly9icm9rZXJjaGVjay5maW5yYS5vcmcvZmlybS9zdW1tYXJ5LzI5MTM4N1cDc3BjQgpkkeinmWT9HWDMUht0cmlzdHJhbWJhbGR3aW45MEBnbWFpbC5jb21YBAAAAc4~)). Investment opportunities are not issued or guaranteed by OpenDeal Broker. Neither the Securities and Exchange Commission nor any federal or state securities regulator has recommended or approved any investment opportunity or the accuracy or completeness of any information or materials provided herein. OpenDeal Broker makes no representations or warranties as to the accuracy of the information herein, and we accept no liability for the same. Offers to sell securities can only be made through official offering documents that contain important information about the investment and the issuers, including risks. Investors should carefully read the offering documents. Investors should conduct their own due diligence and are encouraged to consult with their tax, legal, and financial advisers. [Terms of Use](~/AAQRxQA~/RgRmfCzoP0QaaHR0cHM6Ly9yZXB1YmxpYy5jb20vdGVybXNXA3NwY0IKZJHop5lk_R1gzFIbdHJpc3RyYW1iYWxkd2luOTBAZ21haWwuY29tWAQAAAHO), [Privacy Policy](~/AAQRxQA~/RgRmfCzoP0QcaHR0cHM6Ly9yZXB1YmxpYy5jb20vcHJpdmFjeVcDc3BjQgpkkeinmWT9HWDMUht0cmlzdHJhbWJhbGR3aW45MEBnbWFpbC5jb21YBAAAAc4~), [Business Continuity Plan](~/AAQRxQA~/RgRmfCzoP0Q_aHR0cHM6Ly9yZXB1YmxpYy5jby9jYXBpdGFsX3IvZG93bmxvYWQvYnVzaW5lc3NfY29udGludWl0eV9wbGFuVwNzcGNCCmSR6KeZZP0dYMxSG3RyaXN0cmFtYmFsZHdpbjkwQGdtYWlsLmNvbVgEAAABzg~~), [Additional Risk Disclosures](~/AAQRxQA~/RgRmfCzoP0Q2aHR0cHM6Ly9yZXB1YmxpYy5jby9jYXBpdGFsX3IvZG93bmxvYWQvYWRkaXRpb25hbF9yaXNrVwNzcGNCCmSR6KeZZP0dYMxSG3RyaXN0cmFtYmFsZHdpbjkwQGdtYWlsLmNvbVgEAAABzg~~).